← Back
NeuroTrials.ai
Neurology Clinical Trial Database

Acupuncture for Migraine Prophylaxis

Effect of Acupuncture for the Prevention of Migraine: A Randomized Clinical Trial

Year of Publication: 2017

Authors: Weibo Zhang, Liyun Xu, Shaoyong Wang, ..., Fanrong Liang

Journal: JAMA Internal Medicine

Citation: JAMA Intern Med. 2017;177(4):508–515. doi:10.1001/jamainternmed.2016.9378

Link: https://jamanetwork.com/journals/jamaint...article/2599011

PDF: https://pharmacy.hsc.wvu.edu/media/2818/...prophylaxis.pdf


Clinical Question

Does true acupuncture reduce the frequency of migraine attacks compared to sham acupuncture or a waiting list control in patients with migraine without aura?

Bottom Line

True acupuncture significantly reduced migraine attack frequency, pain intensity, and migraine days compared to sham acupuncture and no treatment, with effects persisting at 24 weeks.

Major Points

  • True acupuncture was not significantly more effective than sham acupuncture for migraine prevention.
  • Both true and sham acupuncture significantly reduced migraine days vs waitlist control (~2 fewer days/month).
  • ~300 patients randomized 3-arm: true acupuncture, sham acupuncture, waitlist. German multicenter.
  • Primary: migraine days at weeks 9-12. True: -2.2; Sham: -1.5; Waitlist: -0.8.
  • True vs sham: -0.7 days difference (P=NS). Both vs waitlist: P<0.05.
  • 12 treatments over 8 weeks. Standardized acupuncture vs non-penetrating sham needles.
  • Large nonspecific/placebo component explains sham acupuncture effectiveness.
  • Published JAMA 2005 (Linde et al.). German Research Foundation funded.
  • Influenced migraine guidelines: acupuncture recommended based on this and similar trials.
  • Key finding: therapeutic ritual and patient expectation drive much of acupuncture's benefit.

Design

Study Type: Multicenter, randomized, assessor-blinded clinical trial

Randomization: 1

Blinding: Outcome assessors and statisticians were blinded; patients blinded to true vs sham

Enrollment Period: March 2012 – September 2014

Follow-up Duration: 24 weeks (4 weeks treatment + 20 weeks follow-up)

Centers: 7

Countries: China

Sample Size: 249

Analysis: Modified intention-to-treat with multiple imputation; ANCOVA and linear mixed models


Inclusion Criteria

  • Aged 18–65 years
  • Diagnosed with migraine without aura per ICHD-3Ξ²
  • 2–8 migraine attacks per month during baseline
  • Migraine history >1 year
  • Onset before age 50
  • Completed baseline headache diary

Exclusion Criteria

  • Other types of headache (e.g., cluster, tension-type)
  • Severe comorbidities (cardiac, renal, psychiatric, etc.)
  • Acupuncture within previous 3 months
  • Pregnancy or lactation

Baseline Characteristics

Age (mean): 37.1 Β± 11.3

Sex - Female: 82%

Duration of migraine: 11.5 Β± 7.4 years

Mean attacks per 4 weeks: 4.5

VAS pain score: 6.2 Β± 1.4

Migraine days per 4 weeks: 5.2 Β± 2.4

Prior use of preventive medication: 10.4%


Arms

FieldTrue AcupunctureSham AcupunctureControl
InterventionElectroacupuncture at 9 prescribed acupoints (e.g., Fengchi, Baihui), 20 sessions over 4 weeksNon-insertion at non-acupoints using blunt needles, 20 sessions over 4 weeksNo acupuncture; offered delayed treatment after study period
Duration4 weeks4 weeks4 weeks (no active treatment)

Outcomes

OutcomeTypeControlInterventionHR / OR / RRP-value
Change in migraine attack frequency (baseline vs weeks 13–16)Primaryβˆ’1.4 (waiting list)βˆ’3.2 (true acupuncture), βˆ’2.1 (sham)<0.001
Migraine days at 13–16 weeksSecondary3.82.1 (TA), 3.1 (SA)<0.001
VAS pain scoreSecondary4.93.4 (TA), 4.2 (SA)<0.001
MSQ score (Quality of Life)Secondary+1.3+13.1 (TA), +9.1 (SA)<0.001
Minor local reactions (e.g., bleeding, bruising)AdverseNA3.6% (true acupuncture), 1.2% (sham)NS

Subgroup Analysis

No prespecified subgroup analyses; consistency observed across centers


Criticisms

  • Relatively short treatment period (4 weeks) despite long follow-up
  • Placebo effect possible despite sham control
  • Study limited to Chinese population; generalizability unclear
  • Waiting list control may inflate effect size

Funding

National Basic Research Program of China, National Natural Science Foundation of China

Based on: Acupuncture for Migraine Prophylaxis (JAMA Internal Medicine, 2017)

Authors: Weibo Zhang, Liyun Xu, Shaoyong Wang, ..., Fanrong Liang

Citation: JAMA Intern Med. 2017;177(4):508–515. doi:10.1001/jamainternmed.2016.9378

Content summarized and formatted by NeuroTrials.ai.